Brought to you by 
IMI buys 75% of Instant Technologies for $44mm in cash/stock
02 Apr 2007
Executive Summary
Continuing to strengthen its drugs-of-abuse diagnostic offerings, Inverness Medical Innovations (IMI) has acquired 75% of Instant Technologies for $43.7mm in cash and stock, paying nearly twice what the private company grossed in 2006 sales.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Saliva-based Testing
- Urine-based Testing
Deal Status
- Final
Deal Type
-
Acquisition
- Includes Contract
- Partial Acquisition
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IMI buys 75% of Instant Technologies for $44mm in cash/stock
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice